Inventor
BLASS BENJAMIN E
US29 patents
⚠️ This page may combine multiple inventors who share the name “BLASS BENJAMIN E”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
UNIV TEMPLE
14 patentsUS11897870B2Feb 13, 2024
5-hydroxytryptamine receptor 7 activity modulators and their method of use
UNIV TEMPLE4 citations85
US10961249B2Mar 30, 2021
Modulators of the sigma-2 receptor and their method of use
UNIV TEMPLE7 citations83
US10676464B2Jun 9, 2020
5-hydroxytryptamine receptor 7 activity modulators and their method of use
UNIV TEMPLE6 citations83
US10287274B2May 14, 2019
5-hydroxytryptamine receptor 7 activity modulators and their method of use
UNIV TEMPLE5 citations83
US10239868B2Mar 26, 2019
5-hydroxytryptamine receptor 7 activity modulators and their method of use
UNIV TEMPLE6 citations83
US9802924B2Oct 31, 2017
5-hydroxytryptamine receptor 7 activity modulators and their method of use
UNIV TEMPLE10 citations83
US11220505B2Jan 11, 2022
5-hydroxytryptamine receptor 7 modulators and their use as therapeutic agents
UNIV TEMPLE3 citations72
US11192871B2Dec 7, 2021
5-hydroxytryptamine receptor 7 activity modulators and their method of use
UNIV TEMPLE4 citations72
US9975879B2May 22, 2018
Beta lactams as modulators of glutamate uptake and methods for use thereof
UNIV TEMPLE2 citations68
US12559494B2Feb 24, 2026
Functionalized lactams as modulators of the 5-hydroxytryptamine receptor 7 and their method of use
UNIV TEMPLE0 citations62
US12503458B2Dec 23, 2025
5-hydroxytryptamine receptor 7 activity modulators and their method of use
UNIV TEMPLE0 citations62
US12338247B2Jun 24, 2025
Modulators of the 5-hydroxytryptamine receptor 7 and their method of use
UNIV TEMPLE0 citations62
US12269809B2Apr 8, 2025
5-hydroxytryptamine receptor 7 activity modulators and their method of use
UNIV TEMPLE0 citations62
US12338245B2Jun 24, 2025
5-hydroxytryptamine receptor 7 modulators and their use as therapeutic agents
UNIV TEMPLE0 citations61
Temple University—Of the Commonwealth System of Higher Education
8 patentsUS11319327B2May 3, 2022
Modulators of the 5-hydroxytryptamine receptor 7 and their method of use
Temple University—Of the Commonwealth System of Higher Education6 citations85
US10858368B2Dec 8, 2020
Modulators of the 5-hydroxytryptamine receptor 7 and their method of use
Temple University—Of the Commonwealth System of Higher Education6 citations83
US10544117B2Jan 28, 2020
5-hydroxytryptamine receptor 7 activity modulators and their method of use
Temple University—Of the Commonwealth System of Higher Education5 citations83
US11820774B2Nov 21, 2023
Modulators of the sigma-2 receptor and their method of use
Temple University—Of the Commonwealth System of Higher Education2 citations72
US11807642B2Nov 7, 2023
5-hydroxytryptamine receptor 7 modulators and their use as therapeutic agents
Temple University—Of the Commonwealth System of Higher Education2 citations72
US9464062B2Oct 11, 2016
Disubstituted oxazolidin-2-ones 5-hydroxytryptamine receptor 2B activity modulators
Temple University—Of the Commonwealth System of Higher Education4 citations68
US12577251B2Mar 17, 2026
Modulators of the sigma-2 receptor and their method of use
Temple University—Of the Commonwealth System of Higher Education0 citations61
US10759750B2Sep 1, 2020
Beta lactams as modulators of glutamate uptake and methods for use thereof
Temple University—Of the Commonwealth System of Higher Education1 citations58
BIOHAVEN PHARM HOLDING CO LTD
5 patentsUS9725427B2Aug 8, 2017
Prodrugs of riluzole and their method of use
BIOHAVEN PHARM HOLDING CO LTD20 citations90
US11440893B2Sep 13, 2022
Prodrugs of riluzole and their method of use
BIOHAVEN PHARM HOLDING CO LTD2 citations71
US10844026B2Nov 24, 2020
Prodrugs of riluzole and their method of use
BIOHAVEN PHARM HOLDING CO LTD2 citations71
US10562870B2Feb 18, 2020
Prodrugs of riluzole and their method of use
BIOHAVEN PHARM HOLDING CO LTD2 citations71
US12172974B2Dec 24, 2024
Prodrugs of riluzole and their method of use
BIOHAVEN PHARM HOLDING CO LTD0 citations61